Research Coordination
Develop innovative sigma-1 receptor-based diagnostics and molecular probes for pharmacology and cellular biology.
Establish a strategic consensus for the clinical exploitation of sigma-1 receptor.
Disseminate sigma-1 receptor knowledge to the scientific and medical communities.
Who we are
European Network for Sigma-1 Receptor as a Therapeutic Opportunity (SIGMA-1 EUROPE)
COST Action CA23156
European Network for Sigma-1 Receptor as a Therapeutic Opportunity (SIGMA-1 EUROPE)
COST Action CA23156
About
A group work
The SIGMA-1 EUROPE network unites researchers and experts across Europe to advance the understanding of sigma-1 receptors physiological and pathological roles, design innovative sigma-1 receptor ligands for biomedical applications, and train young researchers and innovators to explore novel therapeutic opportunities beyond conventional approaches.
Our Mission
The SIGMA-1 EUROPE Action is dedicated to promoting excellence in research and innovation related to sigma-1 receptor physiopathology and therapeutic applications across multiple fields.
Our Principles
The SIGMA-1 EUROPE Action is built on the principles of excellence, openness, and inclusiveness values that have already strengthened collaborations among network members.
Specific Objectives
By driving high-impact research and fostering strong collaborations, SIGMA-1 EUROPE aims to redefine the therapeutic potential of the S1R and contribute to groundbreaking advancements in medicine and pharmacology.
Explore novel therapeutic opportunities
beyond conventional approaches
beyond conventional approaches
The latest from the network
News and insights
Events
Contact UsHave questions?
Have questions?
Get in touch!
Partners
